solifenacin succinate has been researched along with Bladder Cancer in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hodgkinson, L | 1 |
Walton, A | 1 |
Cao, Z; Guo, F; Pan, A; Peng, S; Sun, Y; Wang, H; Wang, L; Wei, R; Xu, C; Zhang, C; Zhang, Z | 1 |
Chung, JM; Ha, HK; Joo, J; Kim, DH; Kim, S; Kim, SH; Seo, HK; Sohn, DW | 1 |
2 trial(s) available for solifenacin succinate and Bladder Cancer
Article | Year |
---|---|
Solifenacin is able to improve the irritative symptoms after transurethral resection of bladder tumors.
Topics: Cystectomy; Cystitis; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Quinuclidines; Remission Induction; Single-Blind Method; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder Diseases; Urinary Bladder Neoplasms; Urinary Bladder, Overactive; Urination Disorders | 2014 |
Evaluation of the Efficacy of Solifenacin for Preventing Catheter-Related Bladder Discomfort After Transurethral Resection of Bladder Tumors in Patients With Non-Muscle Invasive Bladder Cancer: A Prospective, Randomized, Multicenter Study.
Topics: Adult; Aged; Aged, 80 and over; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Pain, Postoperative; Prospective Studies; Severity of Illness Index; Solifenacin Succinate; Treatment Outcome; Urinary Bladder Neoplasms; Urinary Catheterization; Urological Agents | 2017 |
2 other study(ies) available for solifenacin succinate and Bladder Cancer
Article | Year |
---|---|
American Urological Association (AUA) - 112th Annual Meeting (May 12-16, 2017 - Boston, Massachusetts, USA).
Topics: Acetanilides; Administration, Intranasal; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Clinical Trials, Phase III as Topic; Deamino Arginine Vasopressin; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Humans; Hydrogels; Mitomycin; Multicenter Studies as Topic; Nocturia; Randomized Controlled Trials as Topic; Solifenacin Succinate; Thiazoles; United States; Urinary Bladder Neoplasms; Urinary Bladder, Overactive; Urology | 2017 |
Managing overactive bladder symptoms in a palliative care setting.
Topics: Aged, 80 and over; Butylscopolammonium Bromide; Cholinergic Antagonists; Humans; Incontinence Pads; Male; Muscarinic Antagonists; Palliative Care; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder Neoplasms; Urinary Bladder, Overactive; Urinary Tract Infections | 2014 |